EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Yoda1 Inhibits TGFβ-Induced Cardiac Fibroblast Activation via a BRD4-Dependent Pathway

Perwez Alam iD, Sara M Stiens iD, Hunter J Bowles, Hieu Bui, Douglas K Bowles iD

Cells · 04.07.2025 · 14 (13) · 1028

DOI: 10.3390/cells14131028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 04.07.2025. Verfasst von Perwez Alam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, University of Missouri, Columbia, MO 65211, USA. Hauptthemen laut MEDLINE: Fibroblasts, Transforming Growth Factor beta, Transcription Factors, Cell Cycle Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, American Heart Association-American Stroke Association, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrosis represents a pivotal pathological process in numerous diseases, characterized by excessive deposition of extracellular matrix (ECM) that disrupts normal tissue architecture and function. In the heart, cardiac fibrosis significantly impairs both structural integrity and functional capacity, contributing to the progression of heart failure. Central to this process are cardiac fibroblasts (CFs), which, upon activation, differentiate into contractile myofibroblasts, driving pathological ECM accumulation. Transforming growth factor-beta (TGFβ) is a well-established regulator of fibroblast activation; however, the precise molecular mechanisms, particularly the involvement of ion channels, remain poorly understood. Emerging evidence highlights the regulatory role of ion channels, including calcium-activated potassium (KCa) channels, in fibroblast activation. This study elucidates the role of ion channels and investigates the mechanism by which Yoda1, an agonist of the mechanosensitive ion channel Piezo1, modulates TGFβ-induced fibroblast activation. Using NIH/3T3 fibroblasts, we demonstrated that TGFβ-induced activation is regulated by tetraethylammonium (TEA)-sensitive potassium channels, but not by specific K⁺ channel subtypes such as BK, SK, or IK channels. Intriguingly, Yoda1 was found to inhibit TGFβ-induced fibroblast activation through a Piezo1-independent mechanism. Transcriptomic analysis revealed that Yoda1 modulates fibroblast activation by altering gene expression pathways associated with fibrotic processes. Bromodomain-containing protein 4 (BRD4) was identified as a critical mediator of Yoda1’s effects, as pharmacological inhibition of BRD4 with JQ1 or ZL0454 suppressed TGFβ-induced expression of the fibroblast activation marker Periostin (Postn). Conversely, BRD4 overexpression attenuated the inhibitory effects of Yoda1 in both mouse and rat CFs. These results provide novel insights into the pharmacological modulation of TGFβ-induced cardiac fibroblast activation and highlight promising therapeutic targets for the treatment of fibrosis-related cardiac pathologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibroblastsTransforming Growth Factor betaTranscription FactorsCell Cycle ProteinsMyocardiumSignal TransductionNuclear ProteinsAnimalsMiceNIH 3T3 CellsFibrosisRatsIon ChannelsBromodomain Containing Proteins

Stichwörter der Autor:innen

BRD4PeriostinYoda1cardiac fibroblastfibroblast activationion channelsmechanosensitive channels

Substanzen

Transforming Growth Factor betaTranscription FactorsCell Cycle ProteinsBrd4 protein, mouseNuclear ProteinsIon ChannelsBromodomain Containing Proteins

Autor:innen und Institutionen

  • Department of Biomedical Sciences, University of Missouri, Columbia, MO 65211, USA.
  • Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO 65211, USA.

ORCID-Profile: Perwez Alam, Sara M Stiens, Douglas K Bowles

Förderung

  • NHLBI NIH HHS
  • American Heart Association-American Stroke Association
  • NIH HHS
  • NIH
  • AHA Career Development Award

Zitieren

APA

Alam, P., Stiens, S. M., Bowles, H. J., Bui, H., & Bowles, D. K. (2025). Yoda1 Inhibits TGFβ-Induced Cardiac Fibroblast Activation via a BRD4-Dependent Pathway. Cells, 14(13), 1028. https://doi.org/10.3390/cells14131028

Vancouver

Alam P, Stiens SM, Bowles HJ, Bui H, Bowles DK. Yoda1 Inhibits TGFβ-Induced Cardiac Fibroblast Activation via a BRD4-Dependent Pathway. Cells. 2025;14(13):1028. doi:10.3390/cells14131028

BibTeX
@article{Alam2025,
  author = {Alam, Perwez and Stiens, Sara M and Bowles, Hunter J and Bui, Hieu and Bowles, Douglas K},
  title = {Yoda1 Inhibits TGFβ-Induced Cardiac Fibroblast Activation via a BRD4-Dependent Pathway},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {13},
  pages = {1028},
  doi = {10.3390/cells14131028}
}
Kostenlos starten →